相关实验视频
Updated: Jun 17, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
在慢性病中使用抗凝固药
Marco Montomoli1, Boris Gonzales Candía2, Adriana Acosta Barrios3
1Nephrology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain. marcomontomoli@hotmail.it.
Drugs
|August 9, 2024
概括
在慢性病 (CKD) 中管理抗凝血是复杂的,因为有出血和凝血风险. 直接口服抗凝剂 (DOAC) 是有前途的,但它们在晚期CKD中的使用需要进一步研究和仔细考虑.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有慢性病 (CKD) 的患者由于血小板功能和凝血功能受损而面临出血和血栓形成的高风险.
- 在CKD中药物的药理动力学变化可能导致抗凝剂的积累和不良事件,使治疗复杂化.
- 在CKD中,传统的抗凝药管理需要仔细的剂量和监测.
研究的目的:
- 审查慢性病 (CKD) 患者抗凝治疗的挑战和进展.
- 探索直接口服抗凝剂 (DOAC) 在慢性病患者中的作用.
- 在CKD的背景下讨论新出现的策略,如左心房尾闭塞 (LAAO).
主要方法:
- 文献综述和综合关于CKD抗凝剂的当前证据.
- 对抗凝血剂在功能障碍时的药理学考虑的分析.
- 讨论临床试验数据和专家意见的DOACs和LAAO在CKD.
主要成果:
- 慢性病患者在平衡出血和血栓形成风险方面面临着独特的挑战.
- 直接口服抗凝剂 (DOAC) 显示出在非透析CKD患者中改善管理的潜力,但在晚期CKD中数据有限.
- 左心房尾阻塞 (LAAO) 是一种新兴的选择,可以在精选的CKD患者中降低中风风险.
结论:
- 在CKD中抗凝管理需要精确,谨慎和创新的方法.
- 进一步的研究至关重要,以确定DOACs和LAAO在脏疾病的范围内的疗效和安全性.
- 在CKD中优化抗凝剂需要将新疗法与正在进行的研究相结合,以改善患者的治疗结果.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
01:17Factors Affecting Renal Clearance: Renal Impairment
68
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
68
01:11Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
01:27Dialysis
281
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
281
01:22Heart Failure Drugs: Diuretics
353
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
353